These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Significance of phosphoinositide 3 kinase/AKT pathway alterations in endometrial carcinoma]. Yang X; Dong Y; Zhang XM; Liang Y; Zhang Y; Meng YT; Wang Y; Wang W; Nong L; Li T; Liao QP Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):799-804. PubMed ID: 22336203 [TBL] [Abstract][Full Text] [Related]
3. Activated mutant p110α causes endometrial carcinoma in the setting of biallelic Pten deletion. Joshi A; Miller C; Baker SJ; Ellenson LH Am J Pathol; 2015 Apr; 185(4):1104-13. PubMed ID: 25698082 [TBL] [Abstract][Full Text] [Related]
4. Correlation between PTEN expression and PI3K/Akt signal pathway in endometrial carcinoma. Gao Q; Ye F; Xia X; Xing H; Lu Y; Zhou J; Ma D J Huazhong Univ Sci Technolog Med Sci; 2009 Feb; 29(1):59-63. PubMed ID: 19224164 [TBL] [Abstract][Full Text] [Related]
5. JQ1 suppresses tumor growth via PTEN/PI3K/AKT pathway in endometrial cancer. Qiu H; Li J; Clark LH; Jackson AL; Zhang L; Guo H; Kilgore JE; Gehrig PA; Zhou C; Bae-Jump VL Oncotarget; 2016 Oct; 7(41):66809-66821. PubMed ID: 27572308 [TBL] [Abstract][Full Text] [Related]
6. Assessing the efficacy of targeting the phosphatidylinositol 3-kinase/AKT/mTOR signaling pathway in endometrial cancer. Bradford LS; Rauh-Hain A; Clark RM; Groeneweg JW; Zhang L; Borger D; Zukerberg LR; Growdon WB; Foster R; Rueda BR Gynecol Oncol; 2014 May; 133(2):346-52. PubMed ID: 24561032 [TBL] [Abstract][Full Text] [Related]
7. High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability. Cheung LW; Hennessy BT; Li J; Yu S; Myers AP; Djordjevic B; Lu Y; Stemke-Hale K; Dyer MD; Zhang F; Ju Z; Cantley LC; Scherer SE; Liang H; Lu KH; Broaddus RR; Mills GB Cancer Discov; 2011 Jul; 1(2):170-85. PubMed ID: 21984976 [TBL] [Abstract][Full Text] [Related]
8. Gankyrin plays an essential role in estrogen-driven and GPR30-mediated endometrial carcinoma cell proliferation via the PTEN/PI3K/AKT signaling pathway. Zhang J; Yang Y; Zhang Z; He Y; Liu Z; Yu Y; Wu S; Cai B; Feng Y Cancer Lett; 2013 Oct; 339(2):279-87. PubMed ID: 23142288 [TBL] [Abstract][Full Text] [Related]
9. Long Noncoding RNA HOTAIR Promotes Endometrial Carcinoma Cell Proliferation by Binding to PTEN via the Activating Phosphatidylinositol 3-Kinase/Akt Signaling Pathway. Zhang XH; Hu P; Xie YQ; Kang YJ; Li M Mol Cell Biol; 2019 Dec; 39(23):. PubMed ID: 31527078 [TBL] [Abstract][Full Text] [Related]
10. PIK3CA gene mutations in endometrial carcinoma: correlation with PTEN and K-RAS alterations. Velasco A; Bussaglia E; Pallares J; Dolcet X; Llobet D; Encinas M; Llecha N; Palacios J; Prat J; Matias-Guiu X Hum Pathol; 2006 Nov; 37(11):1465-72. PubMed ID: 16949921 [TBL] [Abstract][Full Text] [Related]
11. Mutual contribution of Pten and estrogen to endometrial carcinogenesis in a PtenloxP/loxP mouse model. Saito F; Tashiro H; To Y; Ohtake H; Ohba T; Suzuki A; Katabuchi H Int J Gynecol Cancer; 2011 Nov; 21(8):1343-9. PubMed ID: 21989218 [TBL] [Abstract][Full Text] [Related]
12. Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expression. Huang HN; Lin MC; Tseng LH; Chiang YC; Lin LI; Lin YF; Huang HY; Kuo KT Histopathology; 2015 Mar; 66(4):517-28. PubMed ID: 25195947 [TBL] [Abstract][Full Text] [Related]
13. Correlation between loss of PTEN expression and Akt phosphorylation in endometrial carcinoma. Kanamori Y; Kigawa J; Itamochi H; Shimada M; Takahashi M; Kamazawa S; Sato S; Akeshima R; Terakawa N Clin Cancer Res; 2001 Apr; 7(4):892-5. PubMed ID: 11309338 [TBL] [Abstract][Full Text] [Related]
14. PI3K Pathway Effectors pAKT and FOXO1 as Novel Markers of Endometrioid Intraepithelial Neoplasia. Strickland AL; Rivera G; Lucas E; John G; Cuevas I; Castrillon DH Int J Gynecol Pathol; 2019 Nov; 38(6):503-513. PubMed ID: 30256235 [TBL] [Abstract][Full Text] [Related]
15. A detailed immunohistochemical analysis of the PI3K/AKT/mTOR pathway in lung cancer: correlation with PIK3CA, AKT1, K-RAS or PTEN mutational status and clinicopathological features. Trigka EA; Levidou G; Saetta AA; Chatziandreou I; Tomos P; Thalassinos N; Anastasiou N; Spartalis E; Kavantzas N; Patsouris E; Korkolopoulou P Oncol Rep; 2013 Aug; 30(2):623-36. PubMed ID: 23728071 [TBL] [Abstract][Full Text] [Related]
16. Akt-mediated phosphorylation and activation of estrogen receptor alpha is required for endometrial neoplastic transformation in Pten+/- mice. Vilgelm A; Lian Z; Wang H; Beauparlant SL; Klein-Szanto A; Ellenson LH; Di Cristofano A Cancer Res; 2006 Apr; 66(7):3375-80. PubMed ID: 16585156 [TBL] [Abstract][Full Text] [Related]
17. PI3K/AKT pathway activation in bladder carcinogenesis. Calderaro J; Rebouissou S; de Koning L; Masmoudi A; Hérault A; Dubois T; Maille P; Soyeux P; Sibony M; de la Taille A; Vordos D; Lebret T; Radvanyi F; Allory Y Int J Cancer; 2014 Apr; 134(8):1776-84. PubMed ID: 24122582 [TBL] [Abstract][Full Text] [Related]
18. Evidence for different expression profiles for c-Met, EGFR, PTEN and the mTOR pathway in low and high grade endometrial carcinomas in a cohort of consecutive women. Occurrence of PIK3CA and K-Ras mutations and microsatellite instability. Thoury A; Descatoire V; Kotelevets L; Kannengiesser C; Bertrand G; Theou-Anton N; Frey C; Genestie C; Raymond E; Chastre E; Lehy T; Walker F Histol Histopathol; 2014 Nov; 29(11):1455-66. PubMed ID: 24811063 [TBL] [Abstract][Full Text] [Related]
19. Patterns of PIK3CA alterations in familial colorectal and endometrial carcinoma. Ollikainen M; Gylling A; Puputti M; Nupponen NN; Abdel-Rahman WM; Butzow R; Peltomäki P Int J Cancer; 2007 Aug; 121(4):915-20. PubMed ID: 17471559 [TBL] [Abstract][Full Text] [Related]
20. Exploration of genetic alterations in human endometrial cancer and melanoma: distinct tumorigenic pathways that share a frequent abnormal PI3K/AKT cascade. Ogawa K; Sun C; Horii A Oncol Rep; 2005 Dec; 14(6):1481-5. PubMed ID: 16273242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]